57
Views
0
CrossRef citations to date
0
Altmetric
Review

Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives?

, &
Pages 9-17 | Published online: 01 Feb 2011

References

  • UNAIDSAIDS Epidemic Update122009GenevaUNAIDS2009
  • WHOTowards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector: Progress Report September 2009GenevaWorld Health Organization2009
  • De CockKMGilksCFLoYRGuermaTCan antiretroviral therapy eliminate HIV transmission?Lancet200937396577919038440
  • WoodETyndallMWSpittalPMFactors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programmeAIDS200216694194311919503
  • MalonzaIMRichardsonBAKreissJKBwayoJJStewartGCThe effect of rapid HIV-1 testing on uptake of perinatal HIV-1 interventions: a randomized clinical trialAIDS200317111311812478076
  • TemmermanMQuaghebeurAMwanyumbaFMandaliyaKMother-to-child HIV transmission in resource poor settings: how to improve coverage?AIDS20031781239124212819526
  • GayleHDExpanding access to HIV preventionAIDS Res Ther20063216417638
  • StoverJFahnestockMCoverage of Selected Services for HIV/AIDS Prevention, Care, and Treatment in Low- and Middle-Income Countries in 2005Washington (DC)Constella Futures, POLICY Project2006
  • WilliamsBGLloyd-SmithJOGouwsEThe potential impact of male circumcision on HIV in sub-Saharan AfricaPLoS Med200637e26216822094
  • Abdool KarimQAbdool KarimSSFrohlichJAEffectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in womenScience201032959961168117420643915
  • WeissRASpecial anniversary review: twenty-five years of human immunodeficiency virus research: successes and challengesClin Exp Immunol2008152220121018373700
  • Rerks-NgarmSPitisuttithumPNitayaphanSVaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in ThailandN Engl J Med2009361232209222019843557
  • BunnellRMerminJde CockKMHIV prevention for a threatened continent: implementing positive prevention in AfricaJAMA2006296785585816905790
  • HosseinipourMCohenMSVernazzaPLKashubaADCan antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1?Clin Infect Dis200234101391139511981736
  • LevyARJamesDJohnstonKMThe direct costs of HIV/AIDS careLancet Infect Dis20066317117716500598
  • GranichRMGilksCFDyeCde CockKMWilliamsBGUniversal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelLancet20093739657485719038438
  • GilksCFCrowleySEkpiniRThe WHO public-health approach to antiretroviral treatment against HIV in resource-limited settingsLancet2006368953450551016890837
  • StaszewskiSMorales-RamirezJTashimaKTEfavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 TeamN Engl J Med1999341251865187310601505
  • GallantJEDeJesusEArribasJRTenofovir DF, emtricitabine, and efavirenz vs zidovudine, lamivudine, and efavirenz for HIVN Engl J Med2006354325126016421366
  • Médecins Sans FrontièresUntangling the Web of Antiretroviral Price Reductions13th edMédecins Sans Frontières Report2010 Available from: http://utw.msfaccess.org/Accessed Dec 17 2010
  • JahnAFloydSCrampinACPopulation-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in MalawiLancet200837196241603161118468544
  • MurphyELCollierACKalishLAHighly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV diseaseAnn Intern Med20011351172611434728
  • ViolariACottonMFGibbDMEarly antiretroviral therapy and mortality among HIV-infected infantsN Engl J Med2008359212233224419020325
  • Velasco-HernandezJXGershengornHBBlowerSMCould widespread use of combination antiretroviral therapy eradicate HIV epidemics?Lancet Infect Dis20022848749312150848
  • BunnellREkwaruJPSolbergPChanges in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural UgandaAIDS2006201859216327323
  • BaggaleyRFGarnettGPFergusonNMModelling the impact of antiretroviral use in resource-poor settingsPLoS Med200634e12416519553
  • KilbyJMLeeHYHazelwoodJDTreatment response in acute/ early infection versus advanced AIDS: equivalent first and second phases of HIV RNA declineAIDS200822895796218453855
  • VernazzaPLGilliamBLFleppMEffect of antiviral treatment on the shedding of HIV-1 in semenAIDS19971110124912549256943
  • GuptaPMellorsJKingsleyLHigh viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitorsJ Virol1997718627162759223532
  • DunnDTNewellMLAdesAEPeckhamCSRisk of human immunodeficiency virus type 1 transmission through breastfeedingLancet199234088195855881355163
  • WardJWHolmbergSDAllenJRTransmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibodyN Engl J Med198831884734783422337
  • CameronDWSimonsenJND’CostaLJFemale to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in menLancet1989286604034072569597
  • QuinnTCWawerMJSewankamboNViral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study GroupN Engl J Med20003421392192910738050
  • SperlingRSShapiroDECoombsRWMaternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study GroupN Engl J Med199633522162116298965861
  • HoggRSRhoneSAYipBAntiviral effect of double and triple drug combinations amongst HIV-infected adults: lessons from the implementation of viral load-driven antiretroviral therapyAIDS19981232792849517990
  • VernazzaPLGilliamBLDyerJQuantification of HIV in semen: correlation with antiviral treatment and immune statusAIDS19971189879939223732
  • MarconiVCGranditsGAWeintrobACOutcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the US Military HIV Natural History StudyAIDS Res Ther2010711420507622
  • HartCELennoxJLPratt-PalmoreMCorrelation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tractJ Infect Dis1999179487188210068582
  • Cu-UvinSCaliendoAMReinertSEffect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNAAIDS200014441542110770544
  • Centers for Disease Control and Prevention (CDC)Achievements in public health. Reduction in perinatal transmission of HIV infection – United States, 1985–2005MMWR Morb Mortal Wkly Rep2006552159259716741495
  • European Collaborative StudyMother-to-child transmission of HIV infection in the era of highly active antiretroviral therapyClin Infect Dis200540345846515668871
  • FangGBurgerHGrimsonRMaternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmissionProc Natl Acad Sci U S A1995922612100121048618852
  • GuayLAMusokePFlemingTIntrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialLancet1999354918179580210485720
  • De CockKMFowlerMGMercierEPrevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practiceJAMA200028391175118210703780
  • TovanabutraSRobisonVWongtrakulJMale viral load and heterosexual transmission of HIV-1 subtype E in northern ThailandJ Acquir Immune Defic Syndr200229327528311873077
  • PedrazaMAdel RomeroJRoldánFHeterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partnerJ Acquir Immune Defic Syndr199921212012510360803
  • CastillaJdel RomeroJHernandoVMarincovichBGarcíaSRodríguezCEffectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIVJ Acquir Immune Defic Syndr20054019610116123689
  • MusiccoMLazzarinANicolosiAAntiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual TransmissionArch Intern Med199415417197119768074601
  • Van de VenPPrestageGCrawfordJGrulichAKippaxSSexual risk behaviour increases and is associated with HIV optimism among HIV-negative and HIV-positive gay men in Sydney over the 4 year period to February 2000AIDS200014182951295311153682
  • Van de VenPKippaxSKnoxSPrestageGCrawfordJHIV treatments optimism and sexual behaviour among gay men in Sydney and MelbourneAIDS199913162289229410563714
  • Centers for Disease Control and Prevention (CDC)Increases in unsafe sex and rectal gonorrhea among men who have sex with men – San Francisco, California, 1994–1997MMWR Morb Mortal Wkly Rep199948345489935141
  • BlowerSMGershengornHBGrantRMA tale of two futures: HIV and antiretroviral therapy in San FranciscoScience2000287545365065410649998
  • LawMGPrestageGGrulichAvan de VenPKippaxSModelling the effect of combination antiretroviral treatments on HIV incidenceAIDS200115101287129411426074
  • BlowerSFarmerPPredicting the public health impact of antiretrovirals: preventing HIV in developing countriesAIDScience2003311 Available from: http://aidscience.org/Articles/AIDScience033.aspAccessed December 17, 2010
  • FangCTHsuHMTwuSJDecreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in TaiwanJ Infect Dis2004190587988515295691
  • CrepazNHartTAMarksGHighly active antiretroviral therapy and sexual risk behavior: a meta-analytic reviewJAMA2004292222423615249572
  • BechangeSBunnellRAworATwo-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibitionAIDS Behav201014481682318949550
  • VenkateshKKde BruynGLurieMNDecreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinicsAIDS201024172687269620808202
  • BlowerSBodineEKahnJMcFarlandWThe antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical modelsAIDS200519111415627028
  • LawnSDHarriesADAnglaretXMyerLWoodREarly mortality among adults accessing antiretroviral treatment programmes in sub-Saharan AfricaAIDS200822151897190818784453
  • BunnellROpioAMusinguziJHIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative surveyAIDS200822561762418317003
  • HarriesADSchoutenEJLibambaEScaling up antiretroviral treatment in resource-poor settingsLancet200636795251870187216753490
  • HoDDTime to hit HIV, early and hardN Engl J Med199533374504517616996
  • PhillipsAMorbidity and mortality in the HAART era [abstract]15th Conference on Retroviruses and Opportunistic Infections (CROI 2008)2008 Feb 3–6Boston, MA, USA
  • HargroveJWHumphreyJHMortality among HIV-positive postpartum women with high CD4 cell counts in ZimbabweAIDS2010243F11F1420095074
  • MayRMAndersonRMThe transmission dynamics of human immunodeficiency virus (HIV)Philos Trans R Soc Lond B Biol Sci198832112075656072907158
  • WilliamsBGKorenrompELGouwsESchmidGPAuvertBDyeCHIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populationsJ Infect Dis2006194101450145817054076
  • Cia.gov.c2007 Available from: https://www.cia.gov/Accessed Aug 19 2010
  • AssefaYLeraMUniversal voluntary HIV testing and immediate antiretroviral therapy [correspondence]Lancet20093739669108019328998
  • CohenJAIDS research. Treat everyone now? A ‘radical’ model to stop HIV’s spreadScience20083225907145319056948
  • YuJKChenSCWangKYTrue outcomes for patients on antiretroviral therapy who are “lost to follow-up” in MalawiBull World Health Organ200785755055417768504
  • MillsEJNachegaJBBuchanIAdherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysisJAMA2006296667969016896111
  • FarmerPLéandreFMukherjeeJSCommunity-based approaches to HIV treatment in resource-poor settingsLancet2001358927940440911502340
  • GarnettGPBaggaleyRFTreating our way out of the HIV pandemic: could we, would we, should we?Lancet2009373965791119038439
  • Van LethFPhanuphakPRuxrungthamKComparison of first- line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyLancet200436394171253126315094269
  • YerlySJostSTelentiAInfrequent transmission of HIV-1 drug-resistant variantsAntivir Ther20049337538415259900
  • RoutyJPMachoufNEdwardesMDFactors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in MontrealAIDS200418172305231215577543
  • JürgensRCohenJTarantolaDHeywoodMCarrRUniversal voluntary HIV testing and immediate antiretroviral therapy [correspondence]Lancet200937396691079
  • GranichRMGilksCFDyeCde CockKMWilliamsBGUniversal voluntary HIV testing and immediate antiretroviral therapy – author’s reply [correspondence]Lancet2009373966910801081
  • CorbettELMarstonBChurchyardGJde CockKMTuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatmentLancet2006367951492693716546541
  • WilliamsBGDyeCAntiretroviral drugs for tuberculosis control in the era of HIV/AIDSScience200330156391535153712920302